Optimax Access
Exhibitor
Information
Optimax Access is a premier HEOR consulting firm based in the United Kingdom with a substantial presence in the Netherlands. Our primary mission is to guide pharmaceutical and biotech companies through successful market entries and product launches in the UK and the key EU4 countries.
Our expertise lies in crafting tailored strategies for reimbursement and adoption of products in major global healthcare markets in Europe. We offer a comprehensive range of services, including early market and reimbursement assessment, health economics evidence generation, and health technology assessment dossier submissions.
At the core of our operations is PharmEconix, an innovative and efficient platform for developing and updating health economics evidence at both global and local levels.
We boast a track record of developing over 120 health economic models, authoring more than 100 papers, and experience of working on over 30 HTA and other types of NICE submissions across various therapeutic areas.
As a key member of the IGES Group, a respected 43-year-old German organization with a broad European footprint and over 200 employees, Optimax Access benefits from expanded reach, resources, and capabilities. IGES Group is one of the four consultancies that were invited to provide input for EU-HTA.